本文選題：低能量1064m的Q開關Nd:YAG激光　切入點：激光術后色素沉著　出處：《安徽醫(yī)科大學》2015年碩士論文　論文類型：學位論文

【摘要】：目的：探討低能量1064nm的Q開關Nd：YAG激光對于532nm激光術后產生的炎癥后色素沉著的治療作用及其安全性方法：在中國臺灣北部地區(qū)的兩間皮膚醫(yī)學美容診所,收集一年內治療因532nm波長的Q開關Nd:YAG激光術后產生的炎癥后色素沉著病息治療組與對照組各200例。治療組中炎癥后色素沈著病患單獨應用低能量設置1064nm波長的Q開關Nd:YAG激光治療；對照組則使用三合一美白藥膏治療,分別于治療結束第一個月、第二個月、第三個月后評估臨床療效及患者的滿意度。結果：治療組患者中治療結束第一個月的統(tǒng)計顯示,4.00%的患者是顯效、24.00%的患者被評為好轉、72.00%的患者是無效；第二個月的統(tǒng)計顯示,9.00%的患者被評為痊愈、32.00%的患者是顯效、30.00%的患者有好轉、29.00%患者是無效；第三個月的統(tǒng)計顯示,18.00%的患者被評為痊愈、58.00%的患者為顯效、24%的患者有好轉。而對照組患者中治療結束第一個月的統(tǒng)計顯示,2.00%的患者是顯效、19.00%的患者被評為好轉、79.00%的患者是無效；第二個月的統(tǒng)計顯示,3.00%的患者被評為痊愈、17.00%的患者是顯效、23.00%的患者有好轉、57.00%患者是無娩第三個月的統(tǒng)計顯示,6.00%的患者被評為痊愈、29.00%的患者為顯效、50.00%的患者有好轉、無效的患者有15.00%。治療組患者的痊愈率和有效率分別為18%和76%,而對照組的痊愈率和有效率分別為6%和35%�；颊叩臐M意度調查顯示,治療組患者中治療結束第一個月,不滿意占74%、滿意占22.5%、非常滿意占3.5%；治療結束第二個月時,不滿意占46%、滿意占44%、非常滿意占10%；治療結束第三個月時,不滿意占6%、滿意占65.5%、非常滿意占28.5%。對照組患者中治療結束第一個月,非常不滿意占8.5%,不滿意占72.5%、滿意占19%治療結束第二個月時,非常不滿意占4.5%不滿意占59%、滿意占31.5%、非常滿意占5%；治療結束第三個月時,非常不滿意占10%,不滿意占48%、滿意占34%、非常滿意占8%。結論：使用低能量設置1064nm波長的Q開關Nd：YAG激光治療的炎癥后色素沉著患者,在治療結束第一個月、第二個月、第三個月時臨床療效呈現(xiàn)有效。在治療第三個月后治療組有76%的人有明顯效果,對照組有35%的人有明顯效果,而且激光治療優(yōu)于擦藥。對于炎癥后色素沉著患者,治療上不論激光或是藥物治療都有療效,臨床上可以優(yōu)先選擇激光治療,藥物治療次之。但建議不論激光或是藥物治療,都必須接受三個月以上的療程。Efficacy of low fluence 1064-nm Q-switched Nd:YAG laser in the treatment of 532-nm laser induced postinflammatory
[Abstract]:Objective: to investigate the therapeutic effect and safety of low-energy 1064nm Q-switched Nd:YAG laser on postinflammatory pigmentation after 532 nm laser: two skin medical beauty clinics in the northern part of Taiwan, China. Two hundred cases of post-inflammatory pigmentation caused by 532 nm Q-switched Nd:YAG laser were collected in each group and 200 cases in control group. In the treatment group, patients with post-inflammatory pigmentation were treated with low-energy Q of 1064nm wavelength alone. Switch Nd:YAG laser therapy; The control group was treated with tri-in-one whitening ointment at the end of the first month and the second month, respectively. Results: in the first month after treatment, 4.00% of the patients were significantly effective and 24.00% of the patients were evaluated for improvement and 72.00% of the patients were not effective. The statistics of the second month showed that 9.00% of the patients were assessed as cured 32.00% of the patients were significantly effective 30.00% of the patients had improved and 29.00% of the patients were ineffective; The statistics of the third month showed that 18.00% of the patients were evaluated as cured and 58.00% of the patients were significantly improved, while in the control group, the first month of treatment showed that 2.00% of the patients were significantly effective and 19.00% of the patients were rated as improved 79.00% of the patients were ineffective. Statistics for the second month showed that 3.00% of the patients were rated as cured 17.00% of the patients were significantly improved, 57.00% of the patients had improved and 57.00% of the patients had no delivery. Statistics for the third month showed that 6.00% of the patients were rated as cured 29.00% of the patients were marked effective and 50.00% of the patients had improved. The cure rate and effective rate of the treatment group were 18% and 76, respectively, while the cure rate and the effective rate of the control group were 6% and 35, respectively. The survey of patients' satisfaction showed that the first month of treatment ended in the treatment group. Discontentment accounted for 74, satisfaction accounted for 22.5, and very satisfactory was 3.5. At the end of the second month of treatment, dissatisfied accounted for 46 percent, satisfaction for 44, and satisfaction for 10; and at the end of the third month of treatment, In the control group, the first month of treatment was completed, the first month of treatment was very unsatisfactory, the proportion of very dissatisfied was 8.5, dissatisfied accounted for 72.5 percent, and satisfaction accounted for 19% at the end of the second month of treatment. Very dissatisfied (4.5%) dissatisfied (59x), satisfied (31.5), very satisfied (55.00); at the end of the third month of treatment, Very unsatisfactory accounts for 10%, dissatisfied for 48%, satisfaction for 34%, satisfaction for 8%. Conclusion: patients with post-inflammatory pigmentation treated with low-energy Q-switched Nd:YAG laser at 1064nm wavelength, in the first month, the second month after the end of the treatment, After the third month of treatment, 76% of the patients in the treatment group and 35% in the control group had obvious effects, and laser treatment was better than rubbed medicine. For patients with postinflammatory pigmentation, Both laser and drug therapy are effective in treatment. Laser therapy is the first choice in clinical practice, followed by drug therapy. However, it is recommended that no matter laser or drug therapy, Must undergo more than three months of treatment. Laser of low fluence 1064-nm Q-switched Nd:YAG laser in the treatment of 532-nm laser induced postinflammatory
【學位授予單位】：安徽醫(yī)科大學
【學位級別】：碩士
【學位授予年份】：2015
【分類號】：R62

【相似文獻】

相關期刊論文 前10條

1 王用楫;;用22nm乙型肝炎表面抗原顆粒制備的疫苗[J];國外醫(yī)學.生物制品分冊;1981年04期

2 龔莉;腫瘤轉移抑制基因nm_(23)研究現(xiàn)狀[J];國外醫(yī)學.口腔醫(yī)學分冊;1995年06期

3 李果;梁慧琴;;倍頻532 nm激光治療糖尿病視網膜病變的臨床觀察[J];中國醫(yī)藥指南;2014年16期

4 劉德順;腫瘤轉移抑制基因nm＿23及其在卵巢癌中的表達[J];實用婦產科雜志;1996年01期

5 賀海寧;吳棟;劉洋;;倍頻532 nm激光治療糖尿病視網膜病變療效評價[J];中國激光醫(yī)學雜志;2008年05期

6 吳文娟;李東;邢林莊;陳斌;王國祥;;1064nm激光照射下血管形態(tài)的動態(tài)變化[J];中國激光;2014年03期

7 鐘貴玲;胡瑛;白莉;李素霞;朱蕾;顏玲;;調Q1064nm激光和點陣1064nm激光治療黃褐斑的臨床研究[J];中國美容醫(yī)學;2012年05期

8 錢輝;嚴淑賢;丁蕙琳;竺聞雨;盧忠;;長脈沖1064nm釹:釔-鋁石榴子石激光治療蜘蛛痣臨床觀察[J];臨床皮膚科雜志;2008年08期

9 王永忠,曹友清,馮振卿;胃癌組織中nm~(23)蛋白表達與微血管密度及其轉移的關系研究[J];鎮(zhèn)江醫(yī)學院學報;2001年01期

10 麥躍;周敏;彭雙發(fā);楊國泉;李娟;;Q-開關1064nm激光治療黃褐斑臨床療效觀察[J];實用皮膚病學雜志;2008年04期

相關會議論文 前10條

1 楊天榮;;1064nm長脈沖Nd:YAG激光在人體脫毛的應用[A];第八屆西南五省一市燒傷整形學術會議暨貴州省醫(yī)學會燒傷整形分會2010年學術年會論文匯編[C];2010年

2 文建湘;吳江;徐曉軍;文雁平;蕭天鵬;;高精度光纖陀螺用1550nm細徑保偏光纖的研制[A];全國第十三次光纖通信暨第十四屆集成光學學術會議論文集[C];2007年

3 任龍喜;尹建;焦守國;;Nd:YAG激光(1064nm)與半導體激光(980nm)對髓核組織生物熱效應的對比性研究[A];中國康復醫(yī)學會第十一次全國頸椎病學術會議論文集[C];2009年

4 堯舜;劉云;王祥鵬;劉云;姚迪;王立軍;;13．2W連續(xù)輸出1540nm波段半導體激光陣列模塊[A];第十七屆全國激光學術會議論文集[C];2005年

5 王思威;趙振宇;蔣江;張國強;楊朱黎;;40nm超大規(guī)模集成電路電源網絡IR Drop預估[A];第十五屆計算機工程與工藝年會暨第一屆微處理器技術論壇論文集（A輯）[C];2011年

6 徐世祥;翟惠;楊旋;吳昆;曾和平;;用連續(xù)注入腔內光參量手段實現(xiàn)產生與寬帶794nm光脈沖精確同步的1064nm光脈沖[A];中國光學學會2006年學術大會論文摘要集[C];2006年

7 沈忠偉;王兆華;劉成;魏志義;;基于非共線飛秒光學參量放大的高對比度1053nm超短脈沖激光的產生研究[A];中國光學學會2011年學術大會摘要集[C];2011年

8 任龍喜;尹建;焦守國;;Nd:YAG激光(1064nm)與半導體激光(980nm)對髓核組織生物熱效應的對比性研究[A];第18屆中國康協(xié)肢殘康復學術年會論文選集[C];2009年

9 宋為民;沈靜;金憲強;鄭涵;許愛娥;;波長1540nm點陣激光治療凹陷性痤瘡疤痕[A];2008年浙江省醫(yī)學美容暨整形外科學術會議論文匯編[C];2008年

10 張國強;趙振宇;張民選;王思威;劉戰(zhàn)濤;;40nm工藝互連線延時優(yōu)化研究[A];第十五屆計算機工程與工藝年會暨第一屆微處理器技術論壇論文集（A輯）[C];2011年

相關重要報紙文章 前10條

1 ;臺積電正式采用40nm工藝[N];中國電腦教育報;2008年

2 記者 陳功章　通訊員 瞿軍業(yè);蘭石化8000Nm~(3)/h制氮裝置一次開車成功[N];甘肅經濟日報;2012年

3 劉洪宇;45nm：英特爾跨越制程分水嶺[N];中國計算機報;2007年

4 ;45nm以下銅互連不如碳納米管[N];中國電腦教育報;2008年

5 ;10nm晶體管[N];中國計算機報;2004年

6 本報記者 熊雯琳;英特爾在移動平臺的22nm博弈[N];電腦報;2011年

7 計算機世界實驗室 吳挺;45nm處理器掛帥[N];計算機世界;2007年

8 周童;同方首發(fā)45nm“液晶電視電腦”[N];計算機世界;2008年

9 余侃;英特爾開啟45nm新世界[N];中國電腦教育報;2007年

10 邱洪民;28nm沖擊波筆記本顯卡新格局[N];電腦報;2011年

相關博士學位論文 前2條

1 勞燕鋒;1310nm垂直腔面發(fā)射激光器設計與研制[D];中國科學院研究生院（上海微系統(tǒng)與信息技術研究所）;2007年

2 李瓊;1470nm半導體介入式激光介導的新型人體輪廓塑形方法的臨床研究[D];南方醫(yī)科大學;2013年

相關碩士學位論文 前10條

1 朱志強;基于28nm工藝的低功耗觸發(fā)器設計及優(yōu)化[D];安徽大學;2015年

2 劉兆騰;低能量1064nm的Q開關Nd:YAG激光治療532nm激光術后色素沉著的療效觀察研究[D];安徽醫(yī)科大學;2015年

3 雷o灬，

本文編號：1558682